Bruker BRKR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $197.5M-5.0% | $267M-2.0% | $208.7M-10.4% | $195.3M-10.2% | $207.8M+13.7% | |
| Bsi Calid | $316.3M+12.9% | $331.6M+3.4% | $312.7M+11.9% | $285.8M+7.6% | $280.1M+22.9% | |
| Bsi Nano | $246M-4.1% | $309.1M-2.9% | $266.5M-7.2% | $252.1M-0.2% | $256.6M+6.7% | |
| Energy And Supercon Technologies | $66.8M+12.6% | $71.5M-0.8% | $73.8M+7.4% | $66.3M-4.1% | $59.3M-18.9% | |
| Cost Of Segment Revenue by Business | ||||||
| Bsi Biospin | $102.7M-6.4% | $136.9M+10.1% | $111.2M-2.0% | $108.1M-2.4% | $109.7M+23.1% | |
| Bsi Calid | $139.3M+18.3% | $151.1M+9.3% | $130.7M+7.2% | $125.6M+12.6% | $117.8M+25.6% | |
| Bsi Nano | $120.2M+1.1% | $150.8M+0.9% | $128.7M-5.2% | $125.6M+4.8% | $118.9M+4.3% | |
| Energy And Supercon Technologies | $52.5M+13.1% | $59.3M+3.3% | $60.5M+10.8% | $52.3M+0.6% | $46.4M-20.7% | |
| Operating Income by Business | ||||||
| Adjustments And Reconciling Items | $74.1M+5.9% | —— | —— | —— | $70M— | |
| Bsi Biospin | $28.8M-22.4% | $63M-19.8% | $33.3M-41.4% | $23.1M-50.4% | $37.1M+7.2% | |
| Bsi Calid | $62.6M+1.8% | $71.7M-8.1% | $76M+29.5% | $53.3M-8.7% | $61.5M+20.4% | |
| Bsi Nano | $14.4M-37.7% | $45.1M+2.3% | $23.5M-23.2% | $9.4M-51.0% | $23.1M-22.5% | |
| Energy And Supercon Technologies | $7.6M+8.6% | $5.5M-36.0% | $7M-9.1% | $7.2M-32.1% | $7M-14.6% | |
| Selling General And Administrative Expense by Business | ||||||
| Bsi Biospin | $41.8M+7.2% | $41.5M-5.5% | $41.3M+4.0% | $40.9M+6.8% | $39M+5.4% | |
| Bsi Calid | $81.3M+11.5% | $77.3M+5.0% | $75.7M+8.3% | $76.9M+11.6% | $72.9M+26.1% | |
| Bsi Nano | $68.5M-1.2% | $71.8M-9.8% | $70.2M-8.2% | $72.7M+1.3% | $69.3M+10.0% | |
| Energy And Supercon Technologies | $5.9M+11.3% | $5.7M+9.6% | $5.6M+3.7% | $5.7M+9.6% | $5.3M-7.0% | |
| Total Assets by Business | ||||||
| BSI Bio Spin CALIDNANO And Corporate | $5.98B+3.6% | $6.09B+7.9% | $6.29B— | $6.19B— | $5.77B— | |
| Energy And Supercon Technologies | $194.7M-5.0% | $192.4M-3.7% | $191.3M-3.3% | $191.2M+6.6% | $204.9M+13.6% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Bsi Biospin | $2.4M-25.0% | $1.1M-81.7% | $4.8M-64.2% | $2.3M-39.5% | $3.2M+900% | |
| Bsi Calid | $6.7M-20.2% | $4.3M-72.8% | $7.1M+9.2% | $5.5M-14.1% | $8.4M+58.5% | |
| Bsi Nano | $4.9M0.0% | $15.3M+212% | $3.1M-27.9% | $13.2M+230% | $4.9M-21.0% | |
| Corporate | $2.3M-51.1% | $2.9M-21.6% | $1.5M-64.3% | $6.9M+72.5% | $4.7M+74.1% | |
| Energy And Supercon Technologies | $1.6M-66.7% | $4.5M-28.6% | $2.1M-50.0% | $2.4M-61.9% | $4.8M-36.8% | |
| Research And Development Expense by Business | ||||||
| Bsi Biospin | $24.2M+10.0% | $25.7M+0.4% | $22.8M-0.9% | $23.2M+6.4% | $22M-0.5% | |
| Bsi Calid | $33.1M+18.6% | $31.5M+2.3% | $30.3M+4.8% | $30M+11.9% | $27.9M+10.7% | |
| Bsi Nano | $42.9M-5.3% | $41.4M-8.4% | $44.1M-0.5% | $44.4M+6.5% | $45.3M+34.8% | |
| Energy And Supercon Technologies | $800K+33.3% | $1M+11.1% | $700K-30.0% | $1.1M-15.4% | $600K-14.3% | |
| Restructuring And Related Cost Incurred Cost by Business | ||||||
| Bsi Biospin | $3M— | $8.2M+1,162% | $4.3M+562% | —— | —— | |
| Bsi Calid | $2M— | $4.7M+1,153% | $19.2M+5,020% | —— | —— | |
| Bsi Nano | -$100K— | $5.4M+4,220% | $9.7M+7,660% | —— | —— | |
| Corporate | $300K— | $2.1M— | -$100K— | —— | —— | |
| Restructuring Charges by Business | ||||||
| Bsi Biospin | $2.9M-50.0% | $3.5M+1,650% | $2.2M+83.3% | -$2.5M-1,350% | $5.8M— | |
| Bsi Calid | $1.5M+25.0% | $3.8M+171% | $12.5M+1,686% | $2.2M+175% | $1.2M— | |
| Bsi Nano | $8.3M+938% | $3.4M+143% | $5.2M+333% | $3.6M-7.7% | $800K-78.4% | |
| Corporate | $200K— | $2.1M— | -$100K— | $1.2M— | $0-100% | |
| D&A by Business | ||||||
| Bsi Biospin | $11.7M+12.5% | $11.5M-0.9% | $10.1M-6.5% | $11.2M+7.7% | $10.4M+26.8% | |
| Bsi Calid | $24.6M+24.2% | $25.1M+10.1% | $24M+25.7% | $23.4M+51.9% | $19.8M+102% | |
| Bsi Nano | $17M+1.8% | $16.5M+9.3% | $16.9M-2.3% | $17.1M+7.5% | $16.7M+24.6% | |
| Corporate | $2.4M+71.4% | $2.6M+85.7% | $2.2M+46.7% | $2M+53.8% | $1.4M+7.7% | |
| Energy And Supercon Technologies | $2.6M+23.8% | $2.4M+20.0% | $2.5M+8.7% | $2.4M+14.3% | $2.1M+5.0% | |
| Asset Impairment Charges by Business | ||||||
| Bsi Calid | $2M— | $600K— | $2.1M— | —— | —— | |
| Bsi Nano | $700K— | —— | $16.2M— | —— | —— | |
| Revenue by Product | ||||||
| Product And Service Other | $177M+12.0% | $179.9M+5.2% | $169.4M+9.2% | $162.7M+11.2% | $158.1M+17.3% | |
| Product | $646.4M+0.5% | $797.3M-1.4% | $691.1M-2.6% | $634.7M-3.0% | $643.3M+9.6% | |
| Cost Of Revenue by Product | ||||||
| Product And Service Other | $96M+9.2% | $98.9M+11.4% | $92.1M-4.4% | $93.4M+3.7% | $87.9M+13.9% | |
| Product | $347.6M+7.8% | $429.1M+7.9% | $389M+11.4% | $346.1M+6.2% | $322.3M+10.5% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $134.7M+2.5% | $163.1M-0.7% | $130.7M-7.4% | $127.4M+20.0% | $131.4M+22.8% | |
| CN | $74M-26.9% | $138.1M+21.4% | $121.8M+0.4% | $114.7M-4.7% | $101.2M-12.5% | |
| DE | $62.7M+2.6% | $105.5M+22.5% | $71.3M-4.0% | $59.1M-29.2% | $61.1M-8.5% | |
| Europe Excluding Germany | $258.9M+15.5% | $271.5M-5.4% | $241.2M+11.9% | $213.4M+11.0% | $224.1M+25.8% | |
| Other Country | $71.2M+7.6% | $74M+9.6% | $69.5M-4.9% | $59.9M+9.7% | $66.2M+11.6% | |
| US | $221.9M+2.1% | $225M-13.8% | $226M-5.4% | $222.9M-8.5% | $217.4M+11.6% | |
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate by Geography | ||||||
| CH | 20%0.0pp | —— | —— | —— | 20%0.0pp | |
| DE | 30%0.0pp | —— | —— | —— | 30%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
